Serum thyroglobulin as a prognostic marker before radioiodine ablation in patients with differentiated thyroid cancer

被引：0
|
作者：
Takacsova, E. [1 ]
Kralik, R. [1 ]
Kausitz, J. [1 ]
机构：
[1] St Elisabeth Canc Inst, Bratislava, Slovakia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P639
引用
收藏
页码：S542 / S542
页数：1
相关论文
共 50 条
  • [31] Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients
    Krajewska, Jolanta
    Jarzab, Michal
    Czarniecka, Agnieszka
    Roskosz, Jozef
    Kukulska, Aleksandra
    Handkiewicz-Junak, Daria
    Puch, Zbigniew
    Wygoda, Zbigniew
    Paliczka-Cieslik, Ewa
    Kropinska, Aleksandra
    Gubala, Elzbieta
    Jurecka-Lubieniecka, Beata
    Jarzab, Barbara
    ENDOKRYNOLOGIA POLSKA, 2016, 67 (01) : 2 - 11
  • [32] ELEVATED SERUM THYROGLOBULIN - MARKER OF METASTASES IN DIFFERENTIATED THYROID CARCINOMAS
    VANHERLE, AJ
    ULLER, RP
    JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (02): : 272 - 277
  • [33] SERUM THYROGLOBULIN CONCENTRATIONS AND WHOLE-BODY RADIOIODINE SCAN IN FOLLOW-UP OF DIFFERENTIATED THYROID-CANCER AFTER THYROID-ABLATION
    NGTANGFUI, SC
    HOFFENBERG, R
    MAISEY, MN
    BLACK, EG
    BRITISH MEDICAL JOURNAL, 1979, 2 (6185): : 298 - 300
  • [34] Efficacy of empirical radioiodine therapy in patients with differentiated thyroid cancer and elevated serum thyroglobulin without evidence of structural disease
    Piscopo, L.
    Zampella, E.
    Nappi, C.
    Volpe, F.
    Gaudieri, V.
    Bianco, D.
    Volpicelli, F.
    Falzarano, M.
    Pace, L.
    Cuocolo, A.
    Klain, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S670 - S670
  • [35] MANAGEMENT OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER WHO HAVE POSITIVE SERUM THYROGLOBULIN LEVELS AND NEGATIVE RADIOIODINE SCANS
    CLARK, OH
    HOELTING, T
    THYROID, 1994, 4 (04) : 501 - 505
  • [36] Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer
    Teng Zhao
    Jun Liang
    Zhenqing Guo
    Jiao Li
    Yansong Lin
    Endocrine, 2016, 53 : 166 - 173
  • [37] Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer
    Ilhan Lim
    Seok-ki Kim
    Seung-sik Hwang
    Sun Wook Kim
    Ki Wook Chung
    Han Sung Kang
    Eun Sook Lee
    Annals of Nuclear Medicine, 2012, 26 : 777 - 786
  • [38] Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial
    Jin, Yuchen
    Ruan, Maomei
    Cheng, Lingxiao
    Fu, Hao
    Liu, Min
    Sheng, Shiwei
    Chen, Libo
    THYROID, 2019, 29 (01) : 101 - 110
  • [39] Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer
    Lim, Ilhan
    Kim, Seok-ki
    Hwang, Seung-sik
    Kim, Sun Wook
    Chung, Ki Wook
    Kang, Han Sung
    Lee, Eun Sook
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (10) : 777 - 786
  • [40] Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer
    Zhao, Teng
    Liang, Jun
    Guo, Zhenqing
    Li, Jiao
    Lin, Yansong
    ENDOCRINE, 2016, 53 (01) : 166 - 173
12345